Reference Materials for Measurable Residual Disease (MRD) Monitoring in Circulating Cell-Free DNA

Presented at AMP 2020, this poster describes RMs for the development, validation, and control of MRD assays. We designed our RMs for a tumor/normal MRD workflow as a set of three components based on our Tumor Mutational Burden (TMB) and blood TMB (bTMB) reference materials.